scout
|Videos|September 8, 2017

Toxicities Associated With Rucaparib for the Treatment of Ovarian Cancer

Jonathan Ledermann, MD, professor of medical oncology in the University College London Cancer Institute and director of Cancer Research UK and UCL Cancer Trials Centre, discusses the toxicities associated with rucaparib (Rubraca) for the treatment of ovarian cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME